Norovirus (Experimental)
Norovirus — VLP-Based Experimental Vaccines
Platform: Virus-like particle (VLP)
Leading cause of acute gastroenteritis worldwide — virus-like particle vaccine candidates are in late-stage clinical trials.
EXPERIMENTAL — No licensed vaccine or therapeutic currently approved.
Immunology Sections
Curated section analysis in progress
Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.
Wikipedia Overview
Full article ↗
Norovirus, also known as Norwalk virus, is the most common cause of gastroenteritis. The infection, sometimes referred to as the winter vomiting disease, is characterized by non-bloody diarrhea, vomiting, and stomach pain. Fever or headaches may also occur. Symptoms usually develop 24 hours after being exposed, and recovery typically occurs within one to three days. Complications are uncommon, but may include dehydration, especially in the young, the old, and those with other health problems.
PubMed Literature
Search PubMed ↗No PubMed results retrieved.
Semantic Scholar
Search S2 ↗No Semantic Scholar results retrieved.